New response criteria for lymphomas in clinical trials
نویسندگان
چکیده
منابع مشابه
New response criteria for lymphomas in clinical trials.
Standardized staging and response assessment are critical to the successful conduct of clinical trials. In turn, clinical trials are essential to the development of new and more effective therapy for patients with lymphomas. In the absence of effective agents, response criteria are almost irrelevant. However, with the increasing number of effective therapies, standardized criteria are necessary...
متن کاملCriteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.
Juvenile myelomonocytic leukemia is a rare myeloproliferative disease in young children. While hematopoietic stem cell transplantation remains the only curative therapeutic option for most patients, children with juvenile myelomonocytic leukemia increasingly receive novel agents in phase I-II clinical trials as pre-transplant therapy or therapy for relapse after transplantation. However, respon...
متن کاملResponse Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
Since 1990, the primary criteria used for assessing response to therapy in high-grade gliomas were those developed by Macdonald and colleagues, which incorporated 2-dimensional area measurements of contrast-enhancing tumor regions, corticosteroid dosing, and clinical assessment to arrive at a designation of response, stable disease, or progression. Recent advances in imaging technology and targ...
متن کاملClarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed.
a unique antigen-driven pathologic process. 2 This finding again supports the possibility that the NHL originated from a B-cell clone that was already present and antigenically stimulated at the time of MC onset. We agree that a formal demonstration of the identity of HCV-associated NHLs with B-cell clone(s) that produce RFs could be derived only by a direct comparison of the amino acid (AA)– d...
متن کاملDesiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials
Use of major eligibility criteria is a popular but unstudied folk practice for improving patient screening efficiency for clinical studies. This mixed-methods research study derived the desiderata for major eligibility criteria in breast cancer clinical trials. We randomly selected thirty interventional breast cancer clinical trials conducted at The New York-Presbyterian Hospital on the Columbi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2008
ISSN: 0923-7534
DOI: 10.1093/annonc/mdn191